Happiest Post

Mankind Pharma IPO, Mankind Pharma files DRHP for IPO with SEBI

Mankind Pharma IPO, Mankind Pharma files for IPO with SEBI

Mankind Pharma IPO: Mankind Pharma has filed its DRHP papers with market regulator Securities and Exchange Board of India (SEBI) to raise funds through IPO. This IPO could be one of largest ever in pharmaceutical Industry in India.

Mankind Pharma IPO

    Mankind IPO Update

    According to other reports, the size of Mankind Pharma IPO is expected to be around ₹5,500 crores. If this happens Mankind Pharma could create one of the biggest public issues ever in the pharma sector in India. The IPO will consist of an Offer for Sale (OFS) of around 4 crore equity shares by the promoters and existing shareholders of the company.

    Major promoters of Mankind Pharma include Ramesh Juneja, Rajiv Juneja, Sheetal Arora, Ramesh Juneja Family Trust, Rajiv Juneja Family Trust, and Prem Sheetal Family Trust.

    Also, read about Grey Market Premium of IPO.

    History of Mankind Pharma

    Mankind Pharma was incorporated in the year 1991. Presently Mankind Pharma is one of the largest pharmaceutical companies in India (based on domestic sales). The company is engaged in the development, manufacturing, and marketing of a variety of Pharmaceutical Formulations of Health Products.

    The company operates 23 manufacturing facilities across India including the states of Sikkim, Himachal Pradesh, Rajasthan, Uttarakhand, and Andhra Pradesh as on March 31, 2022. Apart from India, the company's major markets include the United States, Sri Lanka, Bangladesh, and Nepal.

    Also, read Upcoming IPO 2022.

    Product Portfolio of Mankind

    Apart from branded generic drugs, Mankind Pharma's flagship products include Prega-News Pregnancy Testing Kit, Manforce Condom, Gas-O-Fast Ayurvedic Antacid, and acne treatment drug Acnestar. The product names of Mankind Pharma are as follows:
    • Manforce
    • Prega News
    • Gas-O-Fast
    • Codistar
    • Dydroboon
    • Glimestar-M
    • Gudcef
    • Candiforce
    • Unwanted-Kit
    • Amlokind-AT
    • Moxikind-CV


    The company's revenue was ₹5,788.8 crore in the financial year 2020, ₹6,028 crore in the year 2021, and ₹7,594.7 crores in the year 2022. Capital International bought an 11% stake in Mankind from ChrysCapital for $200 million in 2015. Then in April 2018, ChrysCapital again bought a 10% stake for about $350 million.

    Mankind Pharma Financials (in Crores)


    Mankind Pharma IPO Lead Managers 

    • Kotak Mahindra Capital Company Limited
    • Axis Capital Limited
    • J.P. Morgan India Private Limited
    • Jefferies India Private Limited
    • IIFL Securities Limited

    Company Address :

    Mankind Pharma Private Limited
    Okhla Industrial Estate,
    Phase-III, New Delhi 110 020,
    Delhi, India
    Tel: +91 11 4747 6600
    E-mail: investors@mankindpharma.com
    Website: www.mankindpharma.com

    Mankind Pharma IPO Registrar :

    KFin Technologies Limited
    Selenium, Tower B,
    Plot No. 31 and 32 Financial District,
    Nanakramguda, Serilingampally,
    Hyderabad, Rangareddi 500 032,
    Telangana, India
    Tel: +91 40 6716 2222
    E-mail: mankind.ipo@kfintech.com
    Investor Grievance E-mail: einward.ris@kfintech.com
    Website: www.kfintech.com

    Frequently Asked Questions (FAQs)

    What is the size of Mankind IPO?
    The Mankind Pharma IP Size is Approx ₹5,500.

    What is Mankind Pharma IPO Date?
    Mankind Pharma IPO Date is - 2022.

    What is Mankind Pharma IPO Price band?
    Mankind Pharma IPO Price band is ₹- to ₹-.

    What is Mankind Pharma IPO Listing Date?
    Mankind Pharma IPO Listing Date is - 2022

    Important Links:

    Thanks for Visiting. If you have any questions or feedback, don't hesitate to leave a comment.

    Post a Comment